Amyloid-β, Tau protein, and oxidative changes as a physiological compensatory mechanism to maintain CNS plasticity under Alzheimer's disease and other neurodegenerative conditions

In this review, we propose that the neurodegenerative changes in the neurochemistry of amyloid-β (Aβ) aggregation, tau phosphorylation, cytoskeleton rearrangement, oxidative stress, and lipid peroxidation in Alzheimer's disease (AD), and a number of other neurodegenerative diseases, are secondary pathological features. In fact, we believe that these phenomena represent natural compensatory mechanisms for impaired primary neurodegeneration, membrane dynamic deterioration, and/or associated failures of neurotransmission, synaptic function, and neuroplasticity. Physiologically, Aβ, lipid peroxidation, and tau protein may function to sense changes in activity-dependent membrane properties and therefore biochemically modulate membrane lipid homeostasis for more efficient synaptic action. As such, the previously proposed therapeutic tackling of amyloid, tau, oxidative stress, and other brain disease markers may have no ability to cure AD or other devastating central nervous system pathologies and peripheral nervous system diseases. This unfortunate realization provides a wake-up call to the neuroscience community, demanding open-minded approach. © 2009 - IOS.

Authors
Koudinov A. 1, 2, 3, 4 , Kezlya E.5 , Koudinova N. 1, 2, 3 , Berezov T. 1, 2, 3, 4
Publisher
IOS Press
Number of issue
2
Language
English
Pages
381-400
Status
Published
Volume
18
Year
2009
Organizations
  • 1 Berezov Research Laboratory, Russian Academy of Medical Sciences, Moscow, Russian Federation
  • 2 Orechovich Institute of Biomedical Chemistry, RAMS, Moscow, Russian Federation
  • 3 Neurobiology of Lipids, Moscow, Russian Federation
  • 4 Department of Biochemistry, School of Medicine, Peoples' Friendship, University of Russia, Moscow, Russian Federation
  • 5 Interhospital Medical Center Intermedcenter, Moscow, Russian Federation
Keywords
Alzheimer's disease; Amyloid-β; Amyloid-β protein precursor; Apolipoprotein E; Cholesterol; Down's syndrome; High density lipoprotein; Hippocampus; Inclusion-body myositis; Lipid peroxidation; Lipoproteins; Low density lipoprotein; Markers
Date of creation
19.10.2018
Date of change
19.10.2018
Short link
https://repository.rudn.ru/en/records/article/record/3019/